Log In
BCIQ
Print this Print this
 

SKL15508

  Manage Alerts
Collapse Summary General Information
Company SK Biopharmaceuticals Co. Ltd.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSchizophrenia
Indication DetailsTreat cognitive impairment associated with schizophrenia (CIAS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today